How do we make them economically feasible and scalable?
IAN CAMPBELL | Interim Executive Chair | Innovate UK
KEITH THOMPSON | Chair, Pharma Advisory Board | Deep Science Ventures
TIM LUKER | Vice President Emerging Technology and Innovation | Eli Lilly
JAN THIRKETTLE | Chief Development Officer | Freeline
LUCY FOLEY | Director of Biologics | CPI
JONAS MOLLER | Chief Executive Officer | Albumedix
MICHAEL HUNT | Chief Financial Officer | ReNeuron Group plc